English
简体中文
Total: £ 56.28
Published Date: 2026-08-30 | Pages: 114 | Tables: 119 | Medical Care
The global Immunohematology market was valued at US$ 2562 million in 2025 and is anticipated to reach US$ 3418 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Commercially, immunohematology usually refers to pre-transfusion compatibility testing and blood-group serology/molecular typing solutions. The core menu includes ABO/Rh typing, antibody screening, antibody identification, crossmatching, DAT/IAT, antigen typing/extended phenotyping, and selected molecular typing for rare or complex cases. Product formats span gel/cards, reagent red cells, antisera, QC materials, fully/semi-automated analyzers, data-management software, and in some cases reference-laboratory testing services. Upstream inputs include antibodies, reagent RBC materials, plastics/consumables, automation modules, and software; midstream is reagent–instrument system integration; downstream customers are primarily hospital transfusion laboratories/blood banks, independent labs, blood centers, and reference labs.
Immunohematology, as a core interdisciplinary field integrating immunology and hematology, focuses on the interaction between blood components and the immune system, covering key areas such as blood grouping, transfusion safety, diagnosis and treatment of autoimmune hematological diseases, and hematopoietic stem cell transplantation matching. It is an important part of the global healthcare system, and its development is closely linked to multiple global trends, including the upgrading of clinical needs, breakthroughs in technological innovation, and the protection of public health security. The continuous growth of global clinical transfusion demand and the continuous improvement of transfusion safety standards are the core driving forces. The demand for safe blood transfusion in various surgeries, chronic diseases and trauma treatment has promoted the transformation of immunohematology technology towards precision and standardization, reducing the risk of transfusion adverse reactions. The clinical diagnosis and treatment needs of hematological tumors, autoimmune hematological diseases and other diseases have promoted the discipline to extend towards precise immunotherapy and personalized diagnosis and treatment, broadening the research and application boundaries. Technological innovation continues to empower the industry. The application of automated detection platforms, molecular typing technologies, AI-assisted interpretation systems and other technologies has improved detection efficiency and accuracy, promoting the discipline to develop in a diversified and cross-integrated direction. The improvement of the global public health system and the enhancement of blood safety awareness have promoted countries to strengthen blood screening, rare blood type bank construction and standardized construction of immunohematology laboratories. At the same time, the upgrading of medical infrastructure in emerging markets has released new growth for the development of the discipline. The global cooperation between leading enterprises and scientific research institutions has accelerated the global popularization of technological achievements.
Despite the continuous development of the global immunohematology field and the increasing clinical value, it still faces many challenges. High-end technologies and core reagent barriers are strict. The core technologies of precise molecular typing, high-end detection equipment and key reagents are monopolized by a few international leading enterprises. Emerging markets and developing countries have insufficient investment in scientific research, making it difficult to achieve technological breakthroughs and independent substitution, resulting in unbalanced distribution of medical resources. There are regional differences in the development of the discipline. Developed countries, relying on mature medical systems and scientific research strength, focus on cutting-edge technology research and development and clinical application, occupying a dominant position in the industry. However, some developing countries, limited by medical resources and professional talents, have insufficient accessibility of immunohematology detection and diagnosis and treatment services. There is a gap between clinical application and technological transformation. Some cutting-edge technologies have high R&D costs and long certification cycles, making it difficult to quickly land and popularize. At the same time, the shortage of professional and technical talents restricts the promotion and application of disciplinary technologies. In addition, there are regional differences in global industry standards and regulatory norms. Different countries have different requirements for detection processes, reagent certification and quality control, increasing the difficulty of cross-border promotion of technologies and products. Coupled with the safety and ethical controversies of some technologies, the balanced and high-quality development of global immunohematology is further restricted.
This report delivers a comprehensive overview of the global Immunohematology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immunohematology. The Immunohematology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Immunohematology market comprehensively. Regional market sizes by Type, by Application, by Downstream Customers, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immunohematology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bio-Rad Laboratories
Grifols
Immucor (Werfen)
QuidelOrtho
Beckman Coulter
DIAGAST
Hemo bioscience
Institut de Biotechnologies Jacques Boy
MTC INVITRO
AliveDx
AI KANG
Segment by Type
Immunohematology Analyzers and Systems
Immunohematology Reagent
Segment by Downstream Customers
Hospital Transfusion Department/Blood Bank
Blood Center/Blood Collection and Supply Institution
Reference Laboratory/Transplant Center
Others
Segment by Clinical Complexity
Conventional High Frequency
High Complexity/High Added Value
Segment by Application
Blood-Related Diseases
HIV
Hepatitis
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Downstream Customers, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immunohematology companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunohematology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Immunohematology Analyzers and Systems
1.2.3 Immunohematology Reagent
1.3 Market by Downstream Customers
1.3.1 Global Immunohematology Market Size Growth Rate by Downstream Customers: 2021 vs 2025 vs 2032
1.3.2 Hospital Transfusion Department/Blood Bank
1.3.3 Blood Center/Blood Collection and Supply Institution
1.3.4 Reference Laboratory/Transplant Center
1.3.5 Others
1.4 Market by Clinical Complexity
1.4.1 Global Immunohematology Market Size Growth Rate by Clinical Complexity: 2021 vs 2025 vs 2032
1.4.2 Conventional High Frequency
1.4.3 High Complexity/High Added Value
1.5 Market by Application
1.5.1 Global Immunohematology Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Blood-Related Diseases
1.5.3 HIV
1.5.4 Hepatitis
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Immunohematology Market Perspective (2021–2032)
2.2 Global Immunohematology Growth Trends by Region
2.2.1 Global Immunohematology Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Immunohematology Historic Market Size by Region (2021–2026)
2.2.3 Immunohematology Forecasted Market Size by Region (2027–2032)
2.3 Immunohematology Market Dynamics
2.3.1 Immunohematology Industry Trends
2.3.2 Immunohematology Market Drivers
2.3.3 Immunohematology Market Challenges
2.3.4 Immunohematology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunohematology Players by Revenue
3.1.1 Global Top Immunohematology Players by Revenue (2021–2026)
3.1.2 Global Immunohematology Revenue Market Share by Players (2021–2026)
3.2 Global Top Immunohematology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Immunohematology Revenue
3.4 Global Immunohematology Market Concentration Ratio
3.4.1 Global Immunohematology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunohematology Revenue in 2025
3.5 Global Key Players of Immunohematology Head Offices and Areas Served
3.6 Global Key Players of Immunohematology, Products and Applications
3.7 Global Key Players of Immunohematology, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Immunohematology Breakdown Data by Type
4.1 Global Immunohematology Historic Market Size by Type (2021–2026)
4.2 Global Immunohematology Forecasted Market Size by Type (2027–2032)
5 Immunohematology Breakdown Data by Application
5.1 Global Immunohematology Historic Market Size by Application (2021–2026)
5.2 Global Immunohematology Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Immunohematology Market Size (2021–2032)
6.2 North America Immunohematology Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Immunohematology Market Size by Country (2021–2026)
6.4 North America Immunohematology Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunohematology Market Size (2021–2032)
7.2 Europe Immunohematology Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Immunohematology Market Size by Country (2021–2026)
7.4 Europe Immunohematology Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Immunohematology Market Size (2021–2032)
8.2 Asia-Pacific Immunohematology Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Immunohematology Market Size by Region (2021–2026)
8.4 Asia-Pacific Immunohematology Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Immunohematology Market Size (2021–2032)
9.2 Latin America Immunohematology Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Immunohematology Market Size by Country (2021–2026)
9.4 Latin America Immunohematology Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunohematology Market Size (2021–2032)
10.2 Middle East & Africa Immunohematology Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Immunohematology Market Size by Country (2021–2026)
10.4 Middle East & Africa Immunohematology Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Details
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Immunohematology Introduction
11.1.4 Bio-Rad Laboratories Revenue in Immunohematology Business (2021–2026)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Immunohematology Introduction
11.2.4 Grifols Revenue in Immunohematology Business (2021–2026)
11.2.5 Grifols Recent Development
11.3 Immucor (Werfen)
11.3.1 Immucor (Werfen) Company Details
11.3.2 Immucor (Werfen) Business Overview
11.3.3 Immucor (Werfen) Immunohematology Introduction
11.3.4 Immucor (Werfen) Revenue in Immunohematology Business (2021–2026)
11.3.5 Immucor (Werfen) Recent Development
11.4 QuidelOrtho
11.4.1 QuidelOrtho Company Details
11.4.2 QuidelOrtho Business Overview
11.4.3 QuidelOrtho Immunohematology Introduction
11.4.4 QuidelOrtho Revenue in Immunohematology Business (2021–2026)
11.4.5 QuidelOrtho Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Immunohematology Introduction
11.5.4 Beckman Coulter Revenue in Immunohematology Business (2021–2026)
11.5.5 Beckman Coulter Recent Development
11.6 DIAGAST
11.6.1 DIAGAST Company Details
11.6.2 DIAGAST Business Overview
11.6.3 DIAGAST Immunohematology Introduction
11.6.4 DIAGAST Revenue in Immunohematology Business (2021–2026)
11.6.5 DIAGAST Recent Development
11.7 Hemo bioscience
11.7.1 Hemo bioscience Company Details
11.7.2 Hemo bioscience Business Overview
11.7.3 Hemo bioscience Immunohematology Introduction
11.7.4 Hemo bioscience Revenue in Immunohematology Business (2021–2026)
11.7.5 Hemo bioscience Recent Development
11.8 Institut de Biotechnologies Jacques Boy
11.8.1 Institut de Biotechnologies Jacques Boy Company Details
11.8.2 Institut de Biotechnologies Jacques Boy Business Overview
11.8.3 Institut de Biotechnologies Jacques Boy Immunohematology Introduction
11.8.4 Institut de Biotechnologies Jacques Boy Revenue in Immunohematology Business (2021–2026)
11.8.5 Institut de Biotechnologies Jacques Boy Recent Development
11.9 MTC INVITRO
11.9.1 MTC INVITRO Company Details
11.9.2 MTC INVITRO Business Overview
11.9.3 MTC INVITRO Immunohematology Introduction
11.9.4 MTC INVITRO Revenue in Immunohematology Business (2021–2026)
11.9.5 MTC INVITRO Recent Development
11.10 AliveDx
11.10.1 AliveDx Company Details
11.10.2 AliveDx Business Overview
11.10.3 AliveDx Immunohematology Introduction
11.10.4 AliveDx Revenue in Immunohematology Business (2021–2026)
11.10.5 AliveDx Recent Development
11.11 AI KANG
11.11.1 AI KANG Company Details
11.11.2 AI KANG Business Overview
11.11.3 AI KANG Immunohematology Introduction
11.11.4 AI KANG Revenue in Immunohematology Business (2021–2026)
11.11.5 AI KANG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immunohematology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Immunohematology Analyzers and Systems
Table 3. Key Players of Immunohematology Reagent
Table 4. Global Immunohematology Market Size Growth Rate by Downstream Customers (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Hospital Transfusion Department/Blood Bank
Table 6. Key Players of Blood Center/Blood Collection and Supply Institution
Table 7. Key Players of Reference Laboratory/Transplant Center
Table 8. Key Players of Others
Table 9. Global Immunohematology Market Size Growth Rate by Clinical Complexity (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Conventional High Frequency
Table 11. Key Players of High Complexity/High Added Value
Table 12. Global Immunohematology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Immunohematology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Immunohematology Market Size by Region (US$ Million), 2021–2026
Table 15. Global Immunohematology Market Share by Region (2021–2026)
Table 16. Global Immunohematology Forecasted Market Size by Region (US$ Million), 2027–2032
Table 17. Global Immunohematology Market Share by Region (2027–2032)
Table 18. Immunohematology Market Trends
Table 19. Immunohematology Market Drivers
Table 20. Immunohematology Market Challenges
Table 21. Immunohematology Market Restraints
Table 22. Global Immunohematology Revenue by Players (US$ Million), 2021–2026
Table 23. Global Immunohematology Market Share by Players (2021–2026)
Table 24. Global Top Immunohematology Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immunohematology Revenue, 2025
Table 25. Ranking of Global Top Immunohematology Companies by Revenue (US$ Million) in 2025
Table 26. Global 5 Largest Players Market Share by Immunohematology Revenue (CR5 and HHI), 2021–2026
Table 27. Global Key Players of Immunohematology, Headquarters and Area Served
Table 28. Global Key Players of Immunohematology, Products and Applications
Table 29. Global Key Players of Immunohematology, Date of General Availability (GA)
Table 30. Mergers and Acquisitions, Expansion Plans
Table 31. Global Immunohematology Market Size by Type (US$ Million), 2021–2026
Table 32. Global Immunohematology Revenue Market Share by Type (2021–2026)
Table 33. Global Immunohematology Forecasted Market Size by Type (US$ Million), 2027–2032
Table 34. Global Immunohematology Revenue Market Share by Type (2027–2032)
Table 35. Global Immunohematology Market Size by Application (US$ Million), 2021–2026
Table 36. Global Immunohematology Revenue Market Share by Application (2021–2026)
Table 37. Global Immunohematology Forecasted Market Size by Application (US$ Million), 2027–2032
Table 38. Global Immunohematology Revenue Market Share by Application (2027–2032)
Table 39. North America Immunohematology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. North America Immunohematology Market Size by Country (US$ Million), 2021–2026
Table 41. North America Immunohematology Market Size by Country (US$ Million), 2027–2032
Table 42. Europe Immunohematology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Europe Immunohematology Market Size by Country (US$ Million), 2021–2026
Table 44. Europe Immunohematology Market Size by Country (US$ Million), 2027–2032
Table 45. Asia-Pacific Immunohematology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 46. Asia-Pacific Immunohematology Market Size by Region (US$ Million), 2021–2026
Table 47. Asia-Pacific Immunohematology Market Size by Region (US$ Million), 2027–2032
Table 48. Latin America Immunohematology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Latin America Immunohematology Market Size by Country (US$ Million), 2021–2026
Table 50. Latin America Immunohematology Market Size by Country (US$ Million), 2027–2032
Table 51. Middle East & Africa Immunohematology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Middle East & Africa Immunohematology Market Size by Country (US$ Million), 2021–2026
Table 53. Middle East & Africa Immunohematology Market Size by Country (US$ Million), 2027–2032
Table 54. Bio-Rad Laboratories Company Details
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Immunohematology Product
Table 57. Bio-Rad Laboratories Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 58. Bio-Rad Laboratories Recent Development
Table 59. Grifols Company Details
Table 60. Grifols Business Overview
Table 61. Grifols Immunohematology Product
Table 62. Grifols Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 63. Grifols Recent Development
Table 64. Immucor (Werfen) Company Details
Table 65. Immucor (Werfen) Business Overview
Table 66. Immucor (Werfen) Immunohematology Product
Table 67. Immucor (Werfen) Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 68. Immucor (Werfen) Recent Development
Table 69. QuidelOrtho Company Details
Table 70. QuidelOrtho Business Overview
Table 71. QuidelOrtho Immunohematology Product
Table 72. QuidelOrtho Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 73. QuidelOrtho Recent Development
Table 74. Beckman Coulter Company Details
Table 75. Beckman Coulter Business Overview
Table 76. Beckman Coulter Immunohematology Product
Table 77. Beckman Coulter Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 78. Beckman Coulter Recent Development
Table 79. DIAGAST Company Details
Table 80. DIAGAST Business Overview
Table 81. DIAGAST Immunohematology Product
Table 82. DIAGAST Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 83. DIAGAST Recent Development
Table 84. Hemo bioscience Company Details
Table 85. Hemo bioscience Business Overview
Table 86. Hemo bioscience Immunohematology Product
Table 87. Hemo bioscience Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 88. Hemo bioscience Recent Development
Table 89. Institut de Biotechnologies Jacques Boy Company Details
Table 90. Institut de Biotechnologies Jacques Boy Business Overview
Table 91. Institut de Biotechnologies Jacques Boy Immunohematology Product
Table 92. Institut de Biotechnologies Jacques Boy Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 93. Institut de Biotechnologies Jacques Boy Recent Development
Table 94. MTC INVITRO Company Details
Table 95. MTC INVITRO Business Overview
Table 96. MTC INVITRO Immunohematology Product
Table 97. MTC INVITRO Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 98. MTC INVITRO Recent Development
Table 99. AliveDx Company Details
Table 100. AliveDx Business Overview
Table 101. AliveDx Immunohematology Product
Table 102. AliveDx Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 103. AliveDx Recent Development
Table 104. AI KANG Company Details
Table 105. AI KANG Business Overview
Table 106. AI KANG Immunohematology Product
Table 107. AI KANG Revenue in Immunohematology Business (US$ Million), 2021–2026
Table 108. AI KANG Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Immunohematology Picture
Figure 2. Global Immunohematology Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Immunohematology Market Share by Type: 2025 vs 2032
Figure 4. Immunohematology Analyzers and Systems Features
Figure 5. Immunohematology Reagent Features
Figure 6. Global Immunohematology Market Size Comparison by Downstream Customers (US$ Million), 2021–2032
Figure 7. Hospital Transfusion Department/Blood Bank Features
Figure 8. Blood Center/Blood Collection and Supply Institution Features
Figure 9. Reference Laboratory/Transplant Center Features
Figure 10. Others Features
Figure 11. Global Immunohematology Market Size Comparison by Clinical Complexity (US$ Million), 2021–2032
Figure 12. Conventional High Frequency Features
Figure 13. High Complexity/High Added Value Features
Figure 14. Global Immunohematology Market Size by Application (US$ Million), 2021–2032
Figure 15. Global Immunohematology Market Share by Application: 2025 vs 2032
Figure 16. Blood-Related Diseases Case Studies
Figure 17. HIV Case Studies
Figure 18. Hepatitis Case Studies
Figure 19. Immunohematology Report Years Considered
Figure 20. Global Immunohematology Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 21. Global Immunohematology Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Immunohematology Market Share by Region: 2025 vs 2032
Figure 23. Global Immunohematology Market Share by Players in 2025
Figure 24. Global Immunohematology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. The Top 10 and 5 Players Market Share by Immunohematology Revenue in 2025
Figure 26. North America Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. North America Immunohematology Market Share by Country (2021–2032)
Figure 28. United States Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Canada Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Europe Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Immunohematology Market Share by Country (2021–2032)
Figure 32. Germany Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. France Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. U.K. Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Italy Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Russia Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Ireland Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Asia-Pacific Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Immunohematology Market Share by Region (2021–2032)
Figure 40. China Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Japan Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. South Korea Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Southeast Asia Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. India Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Australia & New Zealand Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Latin America Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Immunohematology Market Share by Country (2021–2032)
Figure 48. Mexico Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Brazil Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Middle East & Africa Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Immunohematology Market Share by Country (2021–2032)
Figure 52. Israel Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Saudi Arabia Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. UAE Immunohematology Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 56. Grifols Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 57. Immucor (Werfen) Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 58. QuidelOrtho Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 59. Beckman Coulter Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 60. DIAGAST Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 61. Hemo bioscience Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 62. Institut de Biotechnologies Jacques Boy Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 63. MTC INVITRO Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 64. AliveDx Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 65. AI KANG Revenue Growth Rate in Immunohematology Business (2021–2026)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
